Pyrazinamide
Edina Avdic, Pharm.D., Paul A. Pham, Pharm.D.
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
- TB (active treatment in combination with other antituberculous drugs)
- Treatment of active tuberculosis (in combination with other antituberculous drugs); no longer recommended for treatment of latent tuberculosis infection because of hepatotoxicity.
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2026 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.